Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cancer-Related Impairments Influence Physical Activity in Uterine Cancer Survivors

Identifieur interne : 006625 ( Ncbi/Curation ); précédent : 006624; suivant : 006626

Cancer-Related Impairments Influence Physical Activity in Uterine Cancer Survivors

Auteurs : Sean M. Hammer [États-Unis] ; Justin C. Brown [États-Unis] ; Saya Segal [États-Unis] ; Christina S. Chu [États-Unis] ; Kathryn H. Schmitz [États-Unis]

Source :

RBID : PMC:4386903

Descripteurs français

English descriptors

Abstract

Introduction

The extent to which physical activity (PA) participation among uterine cancer survivors may be limited by physical and functional impairments (PFIs) related to cancer treatment is unknown. We sought to describe PA participation, characterize the prevalence of PFIs, and examine the association between PFI status and PA participation within this population.

Methods

We conducted a study using a mailed survey among uterine cancer survivors who received treatment at a university hospital. We asked about PA and PFIs using validated self-report questionnaires. PA was calculated using metabolic equivalent hours per week (MET-hrs·wk−1). PFI was defined as having one or more of the following symptoms: lower limb lymphedema (LLL), general pain, fatigue, or severe bladder, bowel, or pelvic issues. Ordinal logistic regression was used to quantify the odds ratio (OR) between PA and PFIs.

Results

The response rate to our survey was 43%. Among the 213 study participants, 40%, 13%, 13%, 12%, and 23% reported participating in <3.0, 3.0–8.9, 9.0–17.9, 18.0–26.9, and ≥ 27.0 MET-hrs·wk−1 of PA, respectively. Walking is the preferred mode of exercise for physically active uterine cancer survivors. 53% of survivors experience at least one PFI. The most common PFI is LLL (36.2%), followed by general pain (22.5%). The OR of PFI decreased as MET-hrs·wk−1 of PA increased (OR = 0.51, 95% CI: 0.31–0.84; P=.009).

Conclusion

The majority of uterine cancer survivors experience physical and functional impairments that significantly reduce the likelihood of PA participation. Physical activity recommendations for uterine cancer survivors should take into account treatment-related impairments that can affect PA participation.


Url:
DOI: 10.1249/MSS.0000000000000360
PubMed: 24781886
PubMed Central: 4386903

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:4386903

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cancer-Related Impairments Influence Physical Activity in Uterine Cancer Survivors</title>
<author>
<name sortKey="Hammer, Sean M" sort="Hammer, Sean M" uniqKey="Hammer S" first="Sean M." last="Hammer">Sean M. Hammer</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Brown, Justin C" sort="Brown, Justin C" uniqKey="Brown J" first="Justin C." last="Brown">Justin C. Brown</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Segal, Saya" sort="Segal, Saya" uniqKey="Segal S" first="Saya" last="Segal">Saya Segal</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology; Department of Surgery (Urology), University of Medicine and Dentistry of New Jersey, New Brunswick, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology; Department of Surgery (Urology), University of Medicine and Dentistry of New Jersey, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chu, Christina S" sort="Chu, Christina S" uniqKey="Chu C" first="Christina S." last="Chu">Christina S. Chu</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Divsion of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Divsion of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24781886</idno>
<idno type="pmc">4386903</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386903</idno>
<idno type="RBID">PMC:4386903</idno>
<idno type="doi">10.1249/MSS.0000000000000360</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">003737</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003737</idno>
<idno type="wicri:Area/Pmc/Curation">003736</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003736</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001C97</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001C97</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">001534</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001534</idno>
<idno type="wicri:Area/PubMed/Curation">001534</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001534</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001534</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001534</idno>
<idno type="wicri:Area/Ncbi/Merge">006625</idno>
<idno type="wicri:Area/Ncbi/Curation">006625</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Cancer-Related Impairments Influence Physical Activity in Uterine Cancer Survivors</title>
<author>
<name sortKey="Hammer, Sean M" sort="Hammer, Sean M" uniqKey="Hammer S" first="Sean M." last="Hammer">Sean M. Hammer</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Brown, Justin C" sort="Brown, Justin C" uniqKey="Brown J" first="Justin C." last="Brown">Justin C. Brown</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Segal, Saya" sort="Segal, Saya" uniqKey="Segal S" first="Saya" last="Segal">Saya Segal</name>
<affiliation wicri:level="2">
<nlm:aff id="A2">Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology; Department of Surgery (Urology), University of Medicine and Dentistry of New Jersey, New Brunswick, NJ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology; Department of Surgery (Urology), University of Medicine and Dentistry of New Jersey, New Brunswick</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chu, Christina S" sort="Chu, Christina S" uniqKey="Chu C" first="Christina S." last="Chu">Christina S. Chu</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Divsion of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Divsion of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, PA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Medicine and science in sports and exercise</title>
<idno type="ISSN">0195-9131</idno>
<idno type="eISSN">1530-0315</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cross-Sectional Studies</term>
<term>Disability Evaluation</term>
<term>Fatigue (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Leg</term>
<term>Lymphedema (etiology)</term>
<term>Middle Aged</term>
<term>Motor Activity</term>
<term>Pain (etiology)</term>
<term>Surveys and Questionnaires</term>
<term>Survivors</term>
<term>Uterine Neoplasms (complications)</term>
<term>Uterine Neoplasms (therapy)</term>
<term>Walking</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activité motrice</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Douleur (étiologie)</term>
<term>Enquêtes et questionnaires</term>
<term>Fatigue (étiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jambe</term>
<term>Lymphoedème (étiologie)</term>
<term>Marche à pied</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Survivants</term>
<term>Tumeurs de l'utérus ()</term>
<term>Études transversales</term>
<term>Évaluation de l'incapacité</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Uterine Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Fatigue</term>
<term>Lymphedema</term>
<term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Uterine Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Douleur</term>
<term>Fatigue</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cross-Sectional Studies</term>
<term>Disability Evaluation</term>
<term>Female</term>
<term>Humans</term>
<term>Leg</term>
<term>Middle Aged</term>
<term>Motor Activity</term>
<term>Surveys and Questionnaires</term>
<term>Survivors</term>
<term>Walking</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activité motrice</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jambe</term>
<term>Marche à pied</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Survivants</term>
<term>Tumeurs de l'utérus</term>
<term>Études transversales</term>
<term>Évaluation de l'incapacité</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>Introduction</title>
<p id="P1">The extent to which physical activity (PA) participation among uterine cancer survivors may be limited by physical and functional impairments (PFIs) related to cancer treatment is unknown. We sought to describe PA participation, characterize the prevalence of PFIs, and examine the association between PFI status and PA participation within this population.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">We conducted a study using a mailed survey among uterine cancer survivors who received treatment at a university hospital. We asked about PA and PFIs using validated self-report questionnaires. PA was calculated using metabolic equivalent hours per week (MET-hrs·wk
<sup>−1</sup>
). PFI was defined as having one or more of the following symptoms: lower limb lymphedema (LLL), general pain, fatigue, or severe bladder, bowel, or pelvic issues. Ordinal logistic regression was used to quantify the odds ratio (OR) between PA and PFIs.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">The response rate to our survey was 43%. Among the 213 study participants, 40%, 13%, 13%, 12%, and 23% reported participating in <3.0, 3.0–8.9, 9.0–17.9, 18.0–26.9, and ≥ 27.0 MET-hrs·wk
<sup>−1</sup>
of PA, respectively. Walking is the preferred mode of exercise for physically active uterine cancer survivors. 53% of survivors experience at least one PFI. The most common PFI is LLL (36.2%), followed by general pain (22.5%). The OR of PFI decreased as MET-hrs·wk
<sup>−1</sup>
of PA increased (OR = 0.51, 95% CI: 0.31–0.84;
<italic>P</italic>
=.009).</p>
</sec>
<sec id="S4">
<title>Conclusion</title>
<p id="P4">The majority of uterine cancer survivors experience physical and functional impairments that significantly reduce the likelihood of PA participation. Physical activity recommendations for uterine cancer survivors should take into account treatment-related impairments that can affect PA participation.</p>
</sec>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006625 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 006625 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:4386903
   |texte=   Cancer-Related Impairments Influence Physical Activity in Uterine Cancer Survivors
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:24781886" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024